Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Mexico In-vitro Diagnostics Market: By Product: Reagents, Instruments, Others; By Technology: Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Haematology, Others; By Usability; By End Use; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Mexico In-vitro Diagnostics Market Outlook

The Mexico in-vitro diagnostics market grew a CAGR of 17.1% during the period 2017-2021. Analysis of human samples offers physicians with vital information to properly diagnose, treat, and prevent illnesses. Several leading companies offer in-vitro diagnostic (IVD) solutions that deliver rapid, sensitive results while minimizing cost and complexity. Modern in-vitro diagnostics (IVDs) enable better diagnosis for prevention and management of infectious and chronic diseases. In-vitro diagnostics can help identify early warning signs and individual risk factors, generating new openings for prevention and early intervention. Some in-vitro diagnostics range beyond the laboratory, hospital or doctor’s office, enabling patients with chronic illnesses to self-monitor and manage their own conditions. These factors are expected to drive market growth.

 

Market Likely to be Driven by Advancements in Technology and Demand for Quality Medical Care

In-vitro diagnostic devices (IVDs) are considered medical devices in Mexico; COFEPRIS does not differentiate the regulation between medical devices and in-vitro diagnostic devices. In-vitro diagnostic devices (IVDs) generally comprise reactants, controls, calibrators and equipment or devices with the help of which diagnosis is carried out. It is noteworthy that IVDs could be part of a medical diagnosis equipment and sold with it, but in terms of regulatory treatment, these are considered independent medical devices. For example, a glucometer device is considered medical equipment while the test strips are considered IVDs.

In-vitro diagnostic products are classified as Class I or II, according to diagnosed parameters. In general, the Classification and Grouping Rules lay down that IVDs related to highly infectious or life-threatening illnesses must be considered class II medical devices; the rest are considered class I.

In developing countries, rising levels of income and standards of living are expected to stimulate a new, health-conscious populace seeking quality medical care, and drive the Mexico in-vitro diagnostics market. Key drivers are expected to be growing population, government insurance, patients that are newly insured, and modernized healthcare facilities.

 

Improved Ease of Use and Greater Reliability Likely to Boost Market Growth

In-vitro diagnostics (IVDs) are assays employed to conduct tests on clinical samples taken from the body, including blood, urine, or tissue. The assays seek to screen for disease, identify a medical condition, observe therapy usage, or prevent disease. Nearly seventy percent of medical decisions are made on the basis of data offered by in-vitro diagnostics (IVDs), thus, these have assumed critical importance in patient care. In recent years, IVDs have gained even more popularity due to their capability of saving lives through early identification of medical conditions. The use of IVDs to determine underlying genetic conditions in addition to diagnostic screening could prevent unnecessary suffering by a patient and decrease the scale of treatment required.

Improved ease-of-use and greater reliability has led to use of IVDs in home settings also. For example, users today easily perform tests to monitor blood glucose levels, determine urinary tract infections, monitor ovulation, and confirm pregnancy. Such tests enable individuals to manage their health and offer quick results to enable further medical action. These advantages are expected to drive the Mexico in-vitro diagnostics market.

 

Market Segmentation

By product, the market is segmented into:

  • Reagents
  • Instruments
  • Others

By technology, the market is classified into:

  • Clinical Chemistry
  • Molecular Diagnostics
  • Immuno Diagnostics
  • Haematology
  • Others

By usability, the market is classified into:

  • Disposable IVD Devices
  • Reusable IVD Devices

By end use, the market is divided into:

  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Others

 

Key Industry Players in the Market

The report presents a detailed analysis of the following key players in the Mexico in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Siemens Healthineer AG
  • Abbott Laboratories
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Technology
  • Usability
  • End Use
Breakup by Product
  • Reagents
  • Instruments
  • Others
Breakup by Technology
  • Clinical Chemistry
  • Molecular Diagnostics
  • Immuno Diagnostics
  • Haematology
  • Others
Breakup by Usability
  • Disposable IVD Devices
  • Reusable IVD Devices
Breakup by End Use
  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • F Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Siemens Healthineer AG
  • Abbott Laboratories
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface 
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions   
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Mexico
7    Industry Opportunities and Challenges  
8    Latin America In-Vitro Diagnostics Market Overview

    8.1    Key Industry Highlights
    8.2    Latin America In-Vitro Diagnostics Historical Market (2017-2021) 
    8.3    Latin America In-Vitro Diagnostics Market Forecast (2022-2027)
    8.4    Latin America In-Vitro Diagnostics Market by Country
        8.4.1    Market Share
            8.4.1.1    Brazil
            8.4.1.2    Argentina
            8.4.1.3    Mexico
            8.4.1.4    Others
9    Mexico In-Vitro Diagnostics Market Analysis
    9.1    Key Industry Highlights
    9.2    Mexico In-Vitro Diagnostics Historical Market (2017-2021) 
    9.3    Mexico In-Vitro Diagnostics Market Forecast (2022-2027)
    9.4    Mexico In-Vitro Diagnostics Market by Product
        9.4.1    Reagents
            9.4.1.1    Market Share
            9.4.1.2    Historical Trend (2017-2021)
            9.4.1.3    Forecast Trend (2022-2027)
        9.4.2    Instruments
            9.4.2.1    Market Share
            9.4.2.2    Historical Trend (2017-2021)
            9.4.2.3    Forecast Trend (2022-2027)
        9.4.3    Others
    9.5    Mexico In-Vitro Diagnostics Market by Technology
        9.5.1    Clinical Chemistry
            9.5.1.1    Market Share
            9.5.1.2    Historical Trend (2017-2021)
            9.5.1.3    Forecast Trend (2022-2027)
        9.5.2    Molecular Diagnostics
            9.5.2.1    Market Share
            9.5.2.2    Historical Trend (2017-2021)
            9.5.2.3    Forecast Trend (2022-2027)
        9.5.3    Immuno Diagnostics
            9.5.3.1    Market Share
            9.5.3.2    Historical Trend (2017-2021)
            9.5.3.3    Forecast Trend (2022-2027)
        9.5.4    Haematology
            9.5.4.1    Market Share
            9.5.4.2    Historical Trend (2017-2021)
            9.5.4.3    Forecast Trend (2022-2027)
        9.5.5    Others
    9.6    Mexico In-Vitro Diagnostics Market by Usability
        9.6.1    Disposable IVD Devices
            9.6.1.1    Market Share
            9.6.1.2    Historical Trend (2017-2021)
            9.6.1.3    Forecast Trend (2022-2027)
        9.6.2    Reusable IVD Devices
            9.6.2.1    Market Share
            9.6.2.2    Historical Trend (2017-2021)
            9.6.2.3    Forecast Trend (2022-2027)
    9.7    Mexico In-Vitro Diagnostics Market by End Use
        9.7.1    Diagnostic Laboratories
            9.7.1.1    Market Share
            9.7.1.2    Historical Trend (2017-2021)
            9.7.1.3    Forecast Trend (2022-2027)
        9.7.2    Hospitals and Clinics
            9.7.2.1    Market Share
            9.7.2.2    Historical Trend (2017-2021)
            9.7.2.3    Forecast Trend (2022-2027)
        9.7.3    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    F Hoffmann-La Roche Ltd.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Becton, Dickinson and Company
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Bio-Rad Laboratories Inc.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Siemens Healthineer AG
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Abbott Laboratories
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Latin America In-Vitro Diagnostics Market: Key Industry Highlights, 2017 and 2027
2.    Mexico In-Vitro Diagnostics Market: Key Industry Highlights, 2017 and 2027
3.    Mexico In-Vitro Diagnostics Historical Market: Breakup by Product (USD Million), 2017-2021
4.    Mexico In-Vitro Diagnostics Market Forecast: Breakup by Product (USD Million), 2022-2027
5.    Mexico In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2017-2021
6.    Mexico In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2022-2027
7.    Mexico In-Vitro Diagnostics Historical Market: Breakup by Usability (USD Million), 2017-2021
8.    Mexico In-Vitro Diagnostics Market Forecast: Breakup by Usability (USD Million), 2022-2027
9.    Mexico In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2017-2021
10.    Mexico In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2022-2027
11.    Mexico In-Vitro Diagnostics Market Structure.

Key Questions Answered in the Report

The Mexico in-vitro diagnostics market is projected to grow at a CAGR of 17.1% between 2022 and 2027.

The major drivers of the market include the rising levels of income, growing population, government insurance, newly insured patients, and modernised healthcare facilities.

Advancements in technology and demand for quality medical care are the key industry trends propelling the market's growth.

The various products in the market are reagents and instruments, among others.

Based on technology, the market is segmented into clinical chemistry, molecular diagnostics, immuno diagnostics and haematology, among others.

Based on usability, the market is bifurcated into disposable IVD devices and reusable IVD devices.

The end-uses of the market are hospital and clinics and diagnostic laboratories, among others.

The major players in the industry are F Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Siemens Healthineer AG, and Abbott Laboratories, among others.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER